[Latest] Ultrasound Devices Market to Reach US$ 11,229.9 Million By 2032 | Astute Analytica
Ultrasound devices market growth is propelled by technological advancements and changes in patient demographics.
New Delhi, Feb. 07, 2025 (GLOBE NEWSWIRE) — The global ultrasound devices market valuation is poised to reach US$ 11,229.9 million by 2032, with a CAGR of 4.74% during the forecast period from 2024 to 2032.
For a long time, ultrasound machines have been an important part of the medical imaging industry. They are utilized in different clinical settings due to their multiple applications. Technological advancements and changes in patient demographics as well as other general health care trends across the globe have led to a significant growth in the worldwide market for ultrasound equipment. What is more, portable or handheld devices that can be used at the point of care have gained popularity recently because they are easy to carry around and can be employed almost anywhere.
Download Free Sample Copy @ https://www.astuteanalytica.com/request-sample/ultrasound-devices-market
Conventionally ultrasounds were only done on pregnant women but now they are being done more frequently by radiologists, cardiologists, and even ER doctors among others. One thing that has propelled this growth is new forms of imaging such as 3D or 4D which allow doctors to notice inside their patients’ bodies better than ever before. Governments also invest both publicly and privately into healthcare infrastructures particularly those found in developing countries where access has historically been limited if not nonexistent altogether; for instance, people in the Asia Pacific region spent more than US$ 70 billion on diagnostic imaging alone last year according to recent research.
Increasing Prevalence of Chronic Diseases
With an aging global population and the spread of lifestyle-related causes such as physical inactivity, obesity, and unhealthy diets worldwide, chronic diseases like cancer, cardiovascular disease, and diabetes are becoming more common. According to the World Health Organization (WHO), 71% of all global deaths are due to chronic illness; annually 17.9 million people die from cardiovascular diseases alone. Therefore, prevention should be focused on both early detection and regular monitoring stages due to the rising burden of chronic diseases that have led to augmented usage of ultrasound devices market for diagnosis. They allow visualization of internal organs without invasive surgery or high costs while also helping detect abnormalities that may not be easily seen otherwise.
Echocardiography is a type of diagnostic test that utilizes ultrasound waves to take pictures of the heart. It is commonly utilized for diagnosing and monitoring cardiovascular problems like congenital heart defects, valve diseases, and cardiomyopathy among others. In the same manner, ultrasound is widely employed in early detection and staging for different types of cancers such as breast cancer, liver cancer, or even prostate cancer. The demand for more diagnostic procedures prompted by an expansion in chronic illnesses rates will drive growth within the ultrasound devices market over the coming years; also, awareness of these advantages together with the availability of advanced imaging systems delivering better quality images may contribute towards its growth further. As healthcare industries worldwide struggle against chronic disease epidemics so too shall they adopt greater numbers of ultrasonic devices thereby becoming major players in the global market for them.
Diagnostic Ultrasound Dominates Market, While Therapeutic Ultrasound Shows Promise for Future Treatments
There is no denying that diagnostic ultrasound dominates the global ultrasound devices market with a considerable share of 92.4%. The expected growth rate for this sector is 4.83%, which means it has a substantial role in medical diagnosis. It is demanded in oncology, cardiology, and obstetrics among other specialties due to its broad usage in those areas; moreover, such demand is propelled by the fact that diagnostic ultrasounds can be utilized across multiple disciplines. Besides these utilizes being able to detect tumors more effectively than ever before as well as enhance cardiac assessment accuracy via better prenatal monitoring resolution methods so far only seen developments will further augment them still more.
As chronic diseases and conditions associated with lifestyle become increasingly common globally, there remains an ongoing demand for medical technology such as ultrasound scans – this holds in the ultrasound devices market mainly because they are less invasive compared with other types of tests or examinations that might need body openings. This makes it necessary also to take into account the fact that many people could have been exposed to too much radiation from different sources including X-rays while artificial intelligence (AI) integration on diagnostic machines could revolutionize everything about it forever.
Therapeutic ultrasound (HIFU) has emerged as one area where researchers see potential beyond traditional diagnostics within their field high-intensity focused ultrasound uses powerful sound waves coming together at one point like a magnifying glass can do when burning holes via paper but instead applied deep into human bodies; thus, destroying tissues selectively without surgery which delivers hope towards new horizons for treating cancer among other ailments. If successful enough during the development phase then therapeutic ultrasound would not only transform patient care but also increase the overall utility of ultrasonic devices leading manufacturers and service providers alike to reap huge profits from its commercialization worldwide.
Color Ultrasound Devices Lead Market, Enhanced by 3D/4D Technology and CEUS Advancements.
In 2024, color ultrasound devices accounted for 90.9% of the global ultrasound devices market share and are projected to grow to about 92.2% during the forecast period. This shows that people like these machines because they can show more details than black-and-white ones. The main reasons behind this trend include clearer images, better differentiation between soft tissues, and advanced blood flow assessment abilities among others. With the increasing demand for accuracy in diagnosis, there is no doubt that colored ultrasonography will continue leading in this field. Besides, the creation of three-dimensional/four-dimensional technology allows real-time multi-organ system examination via imaging from different angles thereby giving a more complete view of internal body structures together with their functions; thus, transforming prenatal care and cardiology.
Additionally, contrast-enhanced ultrasound (CEUS) has opened up new opportunities for color ultrasounds in the ultrasound devices market. CEUS utilizes microbubble contrast agents which help enhance the detection of cancer cells by demonstrating how they are supplied with nutrients via blood vessels as well as differentiating them from normal tissues based on perfusion patterns alone thus the growing advancing diagnostic specificity even more. Furthermore, this method can visualize tissue characterization while improving visualization of small abnormal areas that may not be apparent on traditional scans so it represents another area where companies can develop specialized systems or extend the current portfolio range if applicable due availability of required chemicals for use during scanning procedure setups among other factors.
Key Companies
- Canon Medical Systems Corporation
- FUJIFILM OneSite, Inc.
- GE Healthcare
- B. Braun
- Hologic Inc.
- Konica Minolta Inc.
- Koninklijke Philips N.V.
- Mindray Medical International Limited
- Samsung Medison Co., Ltd.
- Siemens Healthier AG
- Analogic Corporation
- Neusoft Corporation
- Trivitron Healthcare
- CHISON Medical Technologies Co. Ltd.
- Terason
- Esaote SpA
- Other Prominent Players
Key Segmentation:
By Technology
- Diagnostic Ultrasound
- Therapeutic Ultrasound
By Display Type
- Color Ultrasound Devices
- Black and White (B/W) Ultrasound Devices
By Portability
- Trolley/Cart-based Ultrasound Devices
- Compact/Handheld Ultrasound Devices
- Point-of-care Ultrasound Devices
By Application
- Radiology/General Imaging
- Cardiology
- Gynecology
- Vascular
- Urology
- Others
By End User
- Hospitals
- Surgical Centers
- Diagnostic Centers
- Ambulatory Surgical Centers
- Maternity Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
- South America
For more information about this report visit: https://www.astuteanalytica.com/industry-report/ultrasound-devices-market
About Astute Analytica
Astute Analytica is a global analytics and advisory company which has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.
Contact Us:
Astute Analytica
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
For Sales Enquiries: sales@astuteanalytica.com
Website: https://www.astuteanalytica.com/
LinkedIn | Twitter | YouTube
CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@astuteanalytica.com Website: https://www.astuteanalytica.com/
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.